DE2646223C2 - - Google Patents

Info

Publication number
DE2646223C2
DE2646223C2 DE2646223A DE2646223A DE2646223C2 DE 2646223 C2 DE2646223 C2 DE 2646223C2 DE 2646223 A DE2646223 A DE 2646223A DE 2646223 A DE2646223 A DE 2646223A DE 2646223 C2 DE2646223 C2 DE 2646223C2
Authority
DE
Germany
Prior art keywords
polypeptide
unmodified
groups
polypeptides
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2646223A
Other languages
German (de)
English (en)
Other versions
DE2646223A1 (de
Inventor
Vernon Cecil Prof. Dublin Ohio Us Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Ohio State University
Original Assignee
The Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Ohio State University filed Critical The Ohio State University
Publication of DE2646223A1 publication Critical patent/DE2646223A1/de
Application granted granted Critical
Publication of DE2646223C2 publication Critical patent/DE2646223C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19762646223 1975-10-14 1976-10-13 Neue verbesserte organische verbindungen Granted DE2646223A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62203175A 1975-10-14 1975-10-14

Publications (2)

Publication Number Publication Date
DE2646223A1 DE2646223A1 (de) 1977-04-28
DE2646223C2 true DE2646223C2 (enExample) 1990-09-27

Family

ID=24492662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762646223 Granted DE2646223A1 (de) 1975-10-14 1976-10-13 Neue verbesserte organische verbindungen

Country Status (13)

Country Link
JP (1) JPS5251017A (enExample)
AU (1) AU513558B2 (enExample)
BE (1) BE847243R (enExample)
DE (1) DE2646223A1 (enExample)
FR (1) FR2327797A2 (enExample)
GB (1) GB1567764A (enExample)
HK (1) HK10883A (enExample)
IE (1) IE44541B1 (enExample)
MY (1) MY8500808A (enExample)
NL (1) NL7611212A (enExample)
NZ (1) NZ182272A (enExample)
SG (1) SG63582G (enExample)
ZA (1) ZA766143B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467782A1 (de) * 1963-07-17 1968-12-12 Behringwerke Ag Verfahren zur Herstellung von kuenstlichen Antigenen
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition

Also Published As

Publication number Publication date
NL7611212A (nl) 1977-04-18
NZ182272A (en) 1985-03-20
IE44541B1 (en) 1981-12-30
JPS5251017A (en) 1977-04-23
BE847243R (fr) 1977-04-13
AU1858476A (en) 1978-04-20
FR2327797B2 (enExample) 1979-03-02
GB1567764A (en) 1980-05-21
DE2646223A1 (de) 1977-04-28
AU513558B2 (en) 1980-12-11
SG63582G (en) 1983-09-09
FR2327797A2 (fr) 1977-05-13
ZA766143B (en) 1978-05-30
HK10883A (en) 1983-03-24
IE44541L (en) 1977-04-14
MY8500808A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
DE69331495T2 (de) Impfstoffe gegen neisseria meningitidis gruppe c
DE2433883C2 (de) Verwendung von physiologisch aktiven Polypeptiden
DE3855536T2 (de) Rezeptoren für wachstumshormone
DE3784720T2 (de) Produkt, praeparat und methode zum bekaempfen der allergien.
DE69213272T2 (de) Zusammensetzung zum Induzieren einer humoralen Anergie gegen ein Immunogen
DE69430251T2 (de) Verbesserte interferon-polymerkonjugate
DE69804974T2 (de) Opioid-konjugate mit endogenen trägerproteinen
DE2744983A1 (de) Mehrwertiger antigen-protein-komplex
DE3650432T2 (de) Verfahren und Verwendung für ortspezifische Aktivierung von Substanzen.
DE3841091A1 (de) Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
DE2805663C3 (enExample)
DE3486341T2 (de) Derivate von Dextran mit antikoagulierenden und antikomplementären Eigenschaften, ihre Herstellung und ihre biologischen Anwendungen.
EP0309863A2 (de) Mittel und Verfahren zur Auslösung einer Immunantwort auf GnRH und Immunsterilisation von Säugern
DE69528074T2 (de) Chitosan induzierte verstärkung
CH650593A5 (de) Verfahren zur herstellung eines antigens und seine verwendung zur produktion eines antiserums.
DE3851455T2 (de) Biologisch wirksame Moleküle.
CH622426A5 (en) Contraceptive composition
DE2825464A1 (de) Biologisch aktive substanz, verfahren zu deren herstellung und dieselbe enthaltendes pharmazeutisches mittel
EP0001443B1 (de) Mittel zur Konzeptionsverhütung und Schwangerschaftsunterbrechung bei Primaten und Verfahren zu ihrer Herstellung
DE2448530C3 (de) Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
DE1902865A1 (de) Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
DE2646223A1 (de) Neue verbesserte organische verbindungen
DE69419910T2 (de) Oxytocinantagonist
DE3854926T2 (de) Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel
DE69432493T2 (de) Immunostimulierender Träger für Impfstoffe

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C07G 7/00

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee